Celeste Krewson, Assistant Editor

In a recent study, patients receiving hybrid fetoscopic repair experienced fewer obstetrical complications than those received open repair.

In a recent study, women with preterm prelabor rupture of membranes had higher rates of intraamniotic infection when a history of cervical excisional treatment was reported.

In a recent study, women with adenomyosis were at greater risks of adverse obstetrical and neonatal events.

In a recent study, high sensitivity and specificity were found for differentiating between benign and malignant lesions when using the Assessment of Different Neoplasias in the Adnexa and Ovarian-Adnexal Reporting and Data System models.

In a recent study, infection with COVID-19 during controlled ovarian stimulation was negatively associated with embryo and blastocyst quality.

In a recent study, higher immunoglobulin G titers were seen in infants of mothers who received messenger RNA COVID-19 vaccination during pregnancy.

In a recent study, women with breast cancer experienced increased biological aging when treated with radiation therapy.

In a recent study, premature and early menopause were more common in women with a history of infertility, miscarriage, or stillbirth.

In a recent study, patients in the preconception period did not discuss sexual dysfunction and distress with health care professionals despite high prevalence.

In a recent study, institutions with restricted or banned abortion access had decreased quality of care for early pregnancy loss.

In a recent study, increased rates of polycystic ovary syndrome (PCOS) diagnoses were found among individuals aged 16 to 20 years in 2019 compared to 2006.

In a recent study, opioid dispensing was increased in patients receiving abdominal hysterectomy compared to laparoscopic or vaginal hysterectomy.

Norgestrel (Opill; HRA Pharma) is the first nonprescription oral contraceptive approved for use in the United States.

In a recent study, different intrapartum transperineal ultrasound methods showed improved accuracy when predicting failed or complicated operative vaginal birth.

The North American Menopause Society is now known as The Menopause Society.

In a recent study, monozygotic twins with an increased birth rate had fewer autism traits and intellectual disability ratings.

A recent article highlighted 6 bottlenecks which must be addressed to improve gender equity in biomedical research.

In a recent study, the risk of cervical intraepithelial neoplasia recurrence was reduced in patients using imiquimod.

In a recent study, increased rates of severe maternal morbidity were observed among hospitals with a lower obstetric volume in rural settings, but not urban settings.

The White House has announced the signing of an executive order from President Biden to allow easier access to contraception in the United States.

In a recent study, decreased use of long acting and permanent methods of contraception was found among patients with opioid use disorder.

A blood test to determine the risks of preeclampsia and severe preeclampsia in pregnant patients has been given approval by the FDA.

A recent article outlined the risk factors, symptoms, and treatment methods associated with premature ovarian insufficiency.

Beth A. Prairie MD MPH FACOG FACPM, discusses how alcohol consumption worsens symptoms of menopause in midlife women.

In a recent study, pregnancies with preterm prelabor rupture of membranes were associated with greater risks of intraamniotic infection, microbial invasion of the amniotic cavity without inflammation, and early-onset neonatal sepsis development in women with a history of cervical excisional treatment.

Hugh Taylor, MD, discusses topic which will be presented at the 4th Annual International Congress on the Future of Women’s Health.

In a recent study, no clinically significant changes in ovarian reserve were found based on COVID-19 vaccination status.

Astellas has announced positive results of a trial evaluating the safety and efficacy of fezolinetant in menopausal women with moderate to severe vasomotor symptoms.

In a recent review, hormone therapy use was associated with gastroesophageal reflux disease.

In a recent review, the associations between components of lifestyle interventions and reductions in gestational weight gain were unclear.